Literature DB >> 25296860

Epigenetic regulation of cardiac myofibril gene expression during heart development.

Weian Zhao1, Lingjuan Liu, Bo Pan, Yang Xu, Jing Zhu, Changlong Nan, Xupei Huang, Jie Tian.   

Abstract

Cardiac gene expression regulation is controlled not only by genetic factors but also by environmental, i.e., epigenetic factors. Several environmental toxic effects such as oxidative stress and ischemia can result in abnormal myofibril gene expression during heart development. Troponin, one of the regulatory myofibril proteins in the heart, is a well-known model in study of cardiac gene regulation during the development. In our previous studies, we have demonstrated that fetal form troponin I (ssTnI) expression in the heart is partially regulated by hormones, such as thyroid hormone. In the present study, we have explored the epigenetic role of histone modification in the regulation of ssTnI expression. Mouse hearts were collected at different time of heart development, i.e., embryonic day 15.5, postnatal day 1, day 7, day 14 and day 21. Levels of histone H3 acetylation (acH3) and histone H3 lysine 9 trimethylation (H3K9me(3)) were detected using chromatin immunoprecipitation assays in slow upstream regulatory element (SURE) domain (TnI slow upstream regulatory element), 300-bp proximal upstream domain and the first intron of ssTnI gene, which are recognized as critical regions for ssTnI regulation. We found that the levels of acH3 on the SURE region were gradually decreased, corresponding to a similar decrease of ssTnI expression in the heart, whereas the levels of H3K9me(3) in the first intron of ssTnI gene were gradually increased. Our results indicate that both histone acetylation and methylation are involved in the epigenetic regulation of ssTnI expression in the heart during the development, which are the targets for environmental factors.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25296860     DOI: 10.1007/s12012-014-9278-7

Source DB:  PubMed          Journal:  Cardiovasc Toxicol        ISSN: 1530-7905            Impact factor:   3.231


  5 in total

Review 1.  Posttranslational Modifications: Emerging Prospects for Cardiac Regeneration Therapy.

Authors:  Ya-Fei Li; Ya-Xin Wang; Hao Wang; Yao Ma; Lian-Sheng Wang
Journal:  J Cardiovasc Transl Res       Date:  2021-05-24       Impact factor: 4.132

2.  DNA methylation regulates mouse cardiac myofibril gene expression during heart development.

Authors:  Yang Xu; Lingjuan Liu; Bo Pan; Jing Zhu; Changlong Nan; Xupei Huang; Jie Tian
Journal:  J Biomed Sci       Date:  2015-10-17       Impact factor: 8.410

3.  Disruption of embryonic ROCK signaling reproduces the sarcomeric phenotype of hypertrophic cardiomyopathy.

Authors:  Kate E Bailey; Guy A MacGowan; Simon Tual-Chalot; Lauren Phillips; Timothy J Mohun; Deborah J Henderson; Helen M Arthur; Simon D Bamforth; Helen M Phillips
Journal:  JCI Insight       Date:  2019-03-05

Review 4.  Mitochondria and metabolic transitions in cardiomyocytes: lessons from development for stem cell-derived cardiomyocytes.

Authors:  Jessica C Garbern; Richard T Lee
Journal:  Stem Cell Res Ther       Date:  2021-03-12       Impact factor: 6.832

Review 5.  Targeting Epigenetic Regulation of Cardiomyocytes through Development for Therapeutic Cardiac Regeneration after Heart Failure.

Authors:  Lindsay Kraus
Journal:  Int J Mol Sci       Date:  2022-10-06       Impact factor: 6.208

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.